title: [Clinical studies on the measurement of urinary tissue polypeptide antigen (TPA) levels using Prolifigen TPA kit "Daiichi"-II in urothelial cancers].
abstract: We have investigated the clinical significance of urinary tissue polypeptide antigen (TPA) as a tumor marker for urothelial cancers. Urinary TPA levels were determined by the immunoradiometric assay of Prolifigen TPA Kit "Daiichi"-II in 486 healthy controls and 1835 patients with various diseases including 526 with urothelial cancers and 140 with prostatic cancer. The mean value of urinary TPA was 199 +/- 213 (1SD)U/1 in 486 healthy controls. 95% of them having a level below 600 U/l. Therefore, 600 U/l was applied as a cut-off level. Positive rates of urothelial cancers and reactivated prostatic cancer were 57.6% (148 of 248 cases) and 45.5% (5 of 11 cases) respectively. On the other hand, the false positive rate of most urological benign diseases was only about 20% except for the acute stage of urinary tract infections and upper urinary tract stones with hydronephrosis. There was no significant difference in the positive rate between urinary TPA level and urinary cytology in urothelial cancers. The combination of both tests raised the positive rate to 73.1%. Therefore, urinary TPA may be useful in the monitoring of urothelial cancers, and the combination of urinary TPA and urinary cytology may increase the diagnostic accuracy.
authors.affiliation: Department of Urology, Okayama University Medical School.
authors.forename: H
authors.initials: H
authors.lastname: Ohmori
authors.forename: T
authors.initials: T
authors.lastname: Ohashi
authors.forename: Y
authors.initials: Y
authors.lastname: Aso
authors.forename: Y
authors.initials: Y
authors.lastname: Kumamoto
authors.forename: H
authors.initials: H
authors.lastname: Hisazumi
authors.forename: Y
authors.initials: Y
authors.lastname: Shiraiwa
authors.forename: T
authors.initials: T
authors.lastname: Kurita
authors.forename: J
authors.initials: J
authors.lastname: Shimazaki
authors.forename: T
authors.initials: T
authors.lastname: Ohkawa
authors.forename: H
authors.initials: H
authors.lastname: Ogawa
mesh_terms: D000951:Antigens, Neoplasm / Q000652:urine*; D014408:Biomarkers, Tumor / Q000652:urine*; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis* / Q000276:immunology / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D010455:Peptides / Q000652:urine*; D011237:Predictive Value of Tests; D011863:Radioimmunoassay; D011933:Reagent Kits, Diagnostic / Q000592:standards; D019396:Tissue Polypeptide Antigen; D014571:Urologic Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000652:urine
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D010455:Peptides; D011933:Reagent Kits, Diagnostic; D019396:Tissue Polypeptide Antigen